Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors

The emergence of omics technologies over the last decade has helped in advancement of research and our understanding of complex diseases like brain cancers. However, barring genomics, no other omics technology has been able to find utility in clinical settings. The recent advancements in mass spectr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Ghantasala, Saicharan, Pai, Medha Gayathri J., Biswas, Deeptarup, Gahoi, Nikita, Mukherjee, Shuvolina, KP, Manubhai, Nissa, Mehar Un, Srivastava, Alisha, Epari, Sridhar, Shetty, Prakash, Moiyadi, Aliasgar, Srivastava, Sanjeeva
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8162214/
https://ncbi.nlm.nih.gov/pubmed/34055594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.548243
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi